Life Sciences Nova Scotia
  • About
    • Who We Are
    • What we do
    • Why work in Nova Scotia?
    • Contact us
  • Members
    • Member Directory
    • Member Benefits
    • Become a member
  • Resources
    • Member Programs
    • News and success stories
    • Member Job Board
  • Events
    • Events
    • BioPort Atlantic
    • Atlantic Precision Medicine Conference
  • Podcast
Select Page

Business Growth Spurs Expansion to Larger Lab Facilities in Halifax for Sona Nanotech Inc.

by administrator | Nov 22, 2018 | News, SONA NanoTech

About Sona Nanotech Inc. Sona Nanotech Inc. is a nanotechnology life sciences firm that has developed two proprietary methods for the manufacture of rod-shaped gold nanoparticles. The principal business carried out and intended to be continued by Sona is the...

Distribution and Development Agreement Signed Between Sona Nanotech Inc and Expedeon

by administrator | Oct 11, 2018 | News, SONA NanoTech

Read the original article here Halifax, Nova Scotia, October 11th, 2018 – Sona Nanotech Inc. (CSE: SONA) today announced the signing of an agreement with global biotech company Expedeon Ltd. (ETR: EXN) for the supply of Sona’s unique gold nanorods for integration into...

Sona Nanotech develops gold nanorods safe for human trials

by administrator | Oct 5, 2018 | News, SONA NanoTech

Read full issue of LINK magazine here. Halifax-based company Sona Nanotech is manufacturing the first ever toxin-free gold nanorods that are safe for researchers to use in human trials to treat numerous diseases. The company, which began as a research project, is now...

Sona Nanotech Inc. Announces Listing On Canadian Securities Exchange

by administrator | Oct 5, 2018 | News, SONA NanoTech

Read the original article here. Halifax, Nova Scotia, October 3, 2018 – Sona Nanotech Inc. (CSE: SONA) (“Sona” or the “Company”) is pleased to announce that the Canadian Securities Exchange (CSE) has approved the Company’s application to list its common shares on the...

World Gold Council: Realising the healthcare potential of gold nanoparticles

by administrator | Jul 5, 2018 | News, SONA NanoTech

See original article here Darren Rowles is CEO and president of Nova Scotia-based biotech firm Sona Nanotech. Having worked with gold nanoparticles for the past 15 years, he explains the role that they currently play in the healthcare industry and their revolutionary...

ACOA: Sona Nanotech Limited Delivering Innovative Treatment Tools to Global Markets

by administrator | May 14, 2018 | News, SONA NanoTech

See original news release here Gold nanorod manufacturer exploring potential of dual revenue streams for diagnostic, life sciences technology May 14, 2018 – Dartmouth, NS – Atlantic Canada Opportunities Agency Helping Atlantic Canadian businesses succeed in...
« Older Entries
Next Entries »

Recent Posts

  • Sona Nanotech’s Cancer Therapy Shows Potential in New Study
  • Twelve Start-ups Selected for First Cohort of 2026-2027 Accelerate
  • Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States
  • ABK Biomedical Closed $35M Financing Round in 2025
  • Elle, MD Named CIX Startup Award Winner
No comments to show.
[buddybot_chat id=1]

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow